Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Net Cash Flow: 2009-2024

Historic Net Cash Flow for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $489.5 million.

  • UNITED THERAPEUTICS's Net Cash Flow fell 227.65% to -$253.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year decrease of 147.92%. This contributed to the annual value of $489.5 million for FY2024, which is 98.58% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Net Cash Flow of $489.5 million as of FY2024, which was up 98.58% from $246.5 million recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Net Cash Flow high stood at $489.5 million for FY2024, and its period low was $300,000 during FY2020.
  • Its 3-year average for Net Cash Flow is $267.5 million, with a median of $246.5 million in 2023.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Net Cash Flow slumped by 99.57% in 2020 and then spiked by 51,933.33% in 2021.
  • Over the past 5 years, UNITED THERAPEUTICS's Net Cash Flow (Yearly) stood at $300,000 in 2020, then soared by 51,933.33% to $156.1 million in 2021, then crashed by 57.46% to $66.4 million in 2022, then surged by 271.23% to $246.5 million in 2023, then soared by 98.58% to $489.5 million in 2024.